Tirzepatide for the Treatment of Concurrent Type 1 Diabetes and Overweight or Obesity

Clinical trial NCT06180616 · NOT_YET_RECRUITING

Trial details

NCT number: NCT06180616
Sponsor: Royal North Shore Hospital
Status: NOT_YET_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Type 1 Diabetes Mellitus Overweight and Obesity

Start date: 2026-12-01
Primary completion: 2028-12-01
Enrollment: 40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.